Litcius/Paper detail

Treatment with Foscarnet after Allogeneic Hematopoietic Cell Transplant (Allo-HCT) Is Associated with Long-Term Loss of Renal Function

Gena G. Foster, Michael J. Grant, Samantha Thomas, Blake Cameron, Doug Raiff, Kelly Corbet, Gavin Loitsch, Christopher Ferreri, Mitchell E. Horwitz

2020Biology of Blood and Marrow Transplantation19 citationsDOIOpen Access PDF

Topics & Concepts

MedicineFoscarnetInterquartile rangeRenal functionNephrotoxicityInternal medicineKidney diseaseGastroenterologyCreatinineCalcineurinUrologyTransplantationHematopoietic stem cell transplantationSurgeryKidneyImmunologyHuman cytomegalovirusGanciclovirVirusCytomegalovirus and herpesvirus researchNeonatal Health and BiochemistryPolyomavirus and related diseases
Treatment with Foscarnet after Allogeneic Hematopoietic Cell Transplant (Allo-HCT) Is Associated with Long-Term Loss of Renal Function | Litcius